Key roles of EMT for adaptive resistance to MEK inhibitor in KRAS mutant lung cancer

Por Kitai, Hidenori, Ebi, Hiromichi
Publicado no Small GTPases (2016)

Improvements of visual function and outer retinal morphology following spontaneous regression of cancer in anti-recoverin cancer-associated retinopathy

Por Suimon, Yuka, Saito, Wataru, Hirooka, Kiriko, Kanda, Atsuhiro, Kitai, Hidenori, Sakakibara-Konishi, Jun, Ishida, Susumu
Publicado no Am J Ophthalmol Case Rep (2017)

Epithelial-to-mesenchymal transition defines feedback activation of receptor tyrosine kinase signaling induced by MEK inhibition in KRAS mutant lung cancer

Por Kitai, Hidenori, Ebi, Hiromichi, Tomida, Shuta, Floros, Konstantinos V., Kotani, Hiroshi, Adachi, Yuta, Oizumi, Satoshi, Nishimura, Masaharu, Faber, Anthony C., Yano, Seiji
Publicado no Cancer Discov (2016)

Recurrence of renal cell carcinoma diagnosed using contralateral adrenal biopsy with endoscopic ultrasound-guided fine-needle aspiration

Por TANIMOTO, AZUSA, TAKEUCHI, SHINJI, YAEGASHI, HIROSHI, KOTANI, HIROSHI, KITAI, HIDENORI, NANJO, SHIGEKI, EBI, HIROMICHI, YAMASHITA, KANAME, MOURI, HISATSUGU, OHTSUBO, KOUSHIRO, IKEDA, HIROKO, YANO, SEIJI
Publicado no Mol Clin Oncol (2016)

Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIM

Por Song, Kyung-A, Niederst, Matthew J., Lochmann, Timothy L., Hata, Aaron N., Kitai, Hidenori, Ham, Jungoh, Floros, Konstantinos V., Hicks, Mark A., Hu, Haichuan, Mulvey, Hillary E., Drier, Yotam, Heisey, Daniel A.R., Hughes, Mark T., Patel, Neha U., Lockerman, Elizabeth L., Garcia, Angel, Gillepsie, Shawn, Archibald, Hannah L., Gomez-Caraballo, Maria, Nulton, Tara J., Windle, Brad E., Piotrowska, Zofia, Sahingur, Sinem E., Taylor, Shirley M., Dozmorov, Mikhail, Sequist, Lecia V., Bernstein, Bradley, Ebi, Hiromichi, Engelman, Jeffrey A., Faber, Anthony C.
Publicado no Clin Cancer Res (2017)